Tag: phase 1 study
September 30, 2019
Cue Biopharma Begins Patient Dosing in Phase 1 Study
The company's Phase 1 study aims to treat patients with PHV16-driven recurrent/metastatic head and neck squamous cell carcinoma. September 19, 2019
PDS Biotechnology Reports Clinical Data for Novel Immunotherapy PDS101
According to the company, 60 percent of evaluable patients exhibited a clinical response in the study. Activity was observed at... August 20, 2019
Mersana Therapeutics Expands Study of XMT-1536
Mersana Therapeutics (NASDAQ:MRSN) has announced it has dosed the first patient in its Phase 1 study of XMT-1536 in patients... August 31, 2018
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study
Altimmune (Nasdaq:ALT) a clinical-stage immunotherapeutics company, today announced initial data from its Phase 1 study of NasoShield under investigation as... May 9, 2018
Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update
Prothena (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience and orphan... April 16, 2018
NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients
NewLink Genetics (NASDAQ:NLNK), today reported initial data from NLG2105, a Phase 1 study evaluating indoximod, its IDO pathway inhibitor, in combination with radiation and...
April 10, 2018